Wed, March 29, 2023

Danielle Antalffy Initiated (ZBH) at Strong Sell and Held Target at $112 on, Mar 29th, 2023

Danielle Antalffy of UBS, Initiated "Zimmer Biomet Holdings, Inc." (ZBH) at Strong Sell and Held Target at $112 on, Mar 29th, 2023.

Danielle has made no other calls on ZBH in the last 4 months.



There are 12 other peers that have a rating on ZBH. Out of the 12 peers that are also analyzing ZBH, 6 agree with Danielle's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Richard Newitter of "Truist Securities" Maintained at Hold with Increased Target to $137 on, Monday, February 6th, 2023
  • Cecilia Furlong of "Morgan Stanley" Maintained at Hold with Increased Target to $140 on, Monday, February 6th, 2023
  • Robbie Marcus of "JP Morgan" Maintained at Hold with Decreased Target to $18 on, Wednesday, January 11th, 2023
  • Matthew O'Brien of "Piper Sandler" Maintained at Hold with Increased Target to $130 on, Thursday, January 5th, 2023
  • Vijay Kumar of "Evercore ISI Group" Downgraded from Buy to Hold and Held Target at $130 on, Tuesday, January 3rd, 2023
  • Joanne Wuensch of "Citigroup" Maintained at Hold with Increased Target to $130 on, Monday, December 12th, 2022


These are the ratings of the 6 analyists that currently disagree with Danielle


  • Matt O'Brien of "Piper Sandler" Upgraded from Hold to Buy on, Friday, March 10th, 2023
  • David Turkaly of "JMP Securities" Reiterated at Buy and Held Target at $145 on, Tuesday, February 7th, 2023
  • Steven Lichtman of "Oppenheimer" Maintained at Buy with Increased Target to $142 on, Monday, February 6th, 2023
  • Rick Wise of "Stifel" Maintained at Strong Buy and Held Target at $150 on, Sunday, February 5th, 2023
  • Shagun Singh of "RBC Capital" Upgraded from Hold to Buy and Increased Target to $141 on, Monday, January 9th, 2023
  • Jayson Bedford of "Raymond James" Upgraded from Hold to Buy and Held Target at $144 on, Thursday, January 5th, 2023